Sitagliptin-induced hemolysis

Sitagliptin is a newer oral hypoglycemic drug of the dipeptidyl peptidase-IV inhibitor class. It appears to be a promising newer oral hypoglycemic agent. The advantages are the absence of hypoglycemia when used as monotherapy and they cause less gain weight. We report a case of sitagliptin-induced h...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Bekur, Ragini, Nagaraja, M.V., Shivashankara, K.N., Stanley, Weena
Format: Artigo
Sprog:Inglês
Udgivet: Medknow Publications 2010
Fag:
Drug Watch
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2959218/
https://ncbi.nlm.nih.gov/pubmed/21206627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.70405
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker